Changes in the total MRI inflammation score are associated with changes in clinical disease activity in RA patients who are escalating therapy in a Treat-to-Target (T2T) regimen

Files in this item

Find Full text

This item appears in the following Collection(s)

Share

Search ResearchSpace


Browse

Statistics